CXCL12 and neoplasm: Inhibition of this pathway has been demonstrated to reduce metastasis in breast cancer, likely through the disruption of CXCL12/CXCR4 signaling, which impairs chemotactic and invasive responses of tumor cells and limits their spread to regional lymph nodes and lungs.